AST SpaceMobile (ASTS) Pulls Back 2% As BlueBird Satellites 11, 12, And 13 Reach Orbit
Shares of AST SpaceMobile (ASTS) fell 2% on Wednesday after surging 11% the prior session, as investors weighed a successful satellite launch against broader market movements. The company confirmed the successful deployment of BlueBird satellites 11, 12, and 13 early Wednesday morning, marking another step forward in its space-based cellular broadband ambitions. SpaceX’s Falcon 9…
IonQ (IONQ) Reports Near-Quadrupling Of Revenue As Quantum Earnings Season Gets Underway
IonQ (IONQ) has delivered its second-quarter earnings report, marking the unofficial start of what analysts are watching as a pivotal earnings season for the quantum computing sector. The results arrive just days after IonQ closed a significant acquisition, adding a layer of strategic momentum to an already closely watched financial update. The revenue figure for…
GE Aerospace (GE) Quietly Sidesteps Persistent Supply Shortage Even As Delinquencies Climb
GE Aerospace has shifted its public narrative away from supply chain shortages, even as those constraints continue to weigh on its ability to serve customers. Just two years ago, management was openly candid about production struggles, with the CEO acknowledging on an earnings call that “our new engine output was disappointing, down 20% sequentially.” The…
Senate Prepares To Vote On Protect College Sports Act, Reshaping Transfers And Athlete Pay
The Protect College Sports Act is heading toward a full Senate vote, potentially arriving as soon as this week amid growing pressure to act before the summer recess. The bill was co-authored by Sen. Ted Cruz (R-Texas) and Sen. Maria Cantwell (D-Wash.), drawing bipartisan support for a sweeping overhaul of college athletics governance. The Senate…
Alphabet (GOOGL) Shares Sink 5.4% As Google Loses Core AI Architects To New Startup
Alphabet (GOOGL) shares fell to a session low, dropping 5.4%, after reports emerged of a sweeping executive shakeup and a string of high-profile talent departures. Jeff Dean, one of Google’s earliest employees and a chief architect of its artificial intelligence strategy for 15 years, is leaving to launch an AI startup focused on scientific discovery….
Novo Nordisk (NVO) Loses GLP-1 Dominance To Eli Lilly (LLY) As Europe Fights To Stay Competitive
Danish drugmaker Novo Nordisk built an early empire on the back of semaglutide, the active ingredient powering both its blockbuster Ozempic and Wegovy treatments. Ozempic was originally developed to treat type 2 diabetes before patients and physicians discovered its dramatic weight-loss effects, setting off a global pharmaceutical gold rush. Novo rebranded semaglutide as Wegovy specifically…
SpaceX Ambitions In AI And Communications Rattle Telecom Stocks, Lift Nvidia (NVDA)
SpaceX is making waves across multiple sectors as the company moves to extend its dominance in space into the AI and communications industries. The company’s aggressive expansion plans sent its own stock down roughly 12%, with shares trading at $110 during Wednesday’s session. The SPCX ETF, which tracks the space industry, fell 7.59% as investors…
D-Wave (QBTS) Publishes Nature Study Showing Quantum Error Correction Breakthrough With Lower Hardware Overhead
D-Wave Quantum Inc. (Nasdaq: QBTS) has announced a major research breakthrough that advances the development of practical, fault-tolerant gate-model quantum computing. The findings, published in the peer-reviewed journal Nature, demonstrate a fast, high-fidelity, two-qubit entangling gate that preserves the error-correction advantages of D-Wave’s superconducting dual-rail qubit architecture. The paper, titled “An entangling gate for dual-rail…
ASTS Short Interest Falls Below 20% As BlueBird Satellite Launch Approaches
AST SpaceMobile (ASTS) is drawing renewed retail investor attention ahead of its next BlueBird satellite launch scheduled for Wednesday at Cape Canaveral. Short interest in the stock has dropped to approximately 19.9% of the public float, falling below the 20% threshold for the first time since June. According to Koyfin data, more than 59.3 million…
Eli Lilly (LLY) Raises Full-Year Revenue Forecast After Q2 Sales Surge 48% On GLP-1 Demand
Eli Lilly and Co. (LLY) shares climbed in premarket trading after the pharmaceutical giant reported a stunning 48% jump in second-quarter revenue, driven by surging demand for its blockbuster weight-loss and diabetes treatments. The company posted adjusted earnings of $8.38 per share, up from $6.31 a share in the same period a year earlier, handily…
